Search results for Evoultion Of Clinical Research

Let us go back to the golden age of simple clinical trials & get rid of big, motivated RCTs.

Very soon, blogs and independent writing will be the only source of unadulterated truths. One such article is shared here written by Adam Kroetsch , formerly in the FDA A review an...

Real-time trials may ‘fundamentally transform’ research

An FDA initiative to implement real-world clinical trials could dramatically accelerate the pace at which new treatments become available to patients, according to physicians from...

<![CDATA[Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?]]>

<![CDATA[The Difference Between Real-Time Clinical Data Review and Real-Time Clinical Trial Oversight]]>

FDA Makes Moves to Modernize Drug Development, Clinical Trial Paradigm

On April 28, 2026, the Food and Drug Administration (FDA) unveiled two major announcements as part of its initiative to “advance the implementation of real-time clinical trials.” I...

FDA Moves Toward Real-Time Clinical Trial Modernization

On April 28, 2026, the U.S. Food and Drug Administration (“FDA”) announced additional steps in its ongoing initiative to advance real-time clinical trial approaches, including proo...

Patient involvement transforms modern clinical research

In medicine, patients are often seen as recipients of care rather than contributors to it. But their lived experiences bring something data alone cannot: context, meaning, and trut...

Patient involvement transforms modern clinical research

In medicine, patients are often seen as recipients of care rather than contributors to it. But their lived experiences bring something data alone cannot: context, meaning, and trut...

Small pools, big ideas: How the rare disease community is reimagining clinical trials

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients has inherently been unfeasible for the rare disease com...

FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review

WEDNESDAY, April 29, 2026 — The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon...

Achieving inclusivity in clinical research

Published: 12 June 2025 This report, ‘Achieving inclusivity in clinical research’, has been jointly published by the Association of Medical Research Charities (AMRC) and Associati...

Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier

As decentralized trials reduce face time with participants, sponsor organizations that treat engagement as an afterthought will pay for it in dropout rates, missing data and failed...

The Changing Landscape of New Approach Methodologies

Now more than ever, NAMs need to be considered a core aspect of modern drug development – and scientists, decision-makers, regulators and governments must keep pace with this evolv...

Patient diversity in clinical trials: why we need practices to change

Publisher: Innovative Trials Published: 2020 This analysis looks at the issue of patient diversity in clinical trials, why there is a lack of diversity in clinical trial patients...

Nova Scotia creates new pathways for medical research

HALIFAX – For decades, participation in medical research in Nova Scotia often depended on timing, geography, or chance. A patient might never hear about a clinical trial because th...

Innovative Approach Enhances Health Research in Rural Communities

Randomised controlled trials (RCTs) have long been hailed as the pinnacle of clinical research, setting the gold standard for evaluating the efficacy of medical interventions. Howe...

European EHR/EPR Market Enters Research-Ready Era as Clinical Trials and Real-World Evidence Move Into the Hospital Data...

Q1-Q2 2026 European provider-user Black Book Research survey finds data valorisation, governed secondary use, cohort discovery, trial feasibility and RWE readiness now defining the...

FDA announces real-time clinical trials, request for information

The Food and Drug Administration April 28 announced its plan to advance the implementation of real-time clinical trials, which invite participants to supply reports and data to the...

Executing biomarker-driven oncology trials

Why biomarker-driven oncology trials require new thinking across patient recruitment, assay development and regulatory strategy.

<![CDATA[Building Operational Visibility in Clinical Trials: Q&A with Deepak Prakash]]>

<![CDATA[FDA’s New Pilot Program and Real-Time Review of Clinical Data]]>

<![CDATA[FDA’s Shift Signals a New Era for Data-Driven Drug Development]]>

Blockchain Smart Contracts for Automating Clinical Trials: Systematic Review and Proposed System Architecture

Background: Blockchain technologies have revolutionized the financial sector through their ability to generate immutable, cryptographically secure records. Clinical trials and heal...

Is Industry Shaping Canada’s Research Ethics Ecosystem?

Clinical trials are the process through which new medicines are tested before they can be approved for sale. The post Is Industry Shaping Canada’s Research Ethics Ecosystem? appear...